Researchers at Baylor College of Medicine and collaborating institutions have engineered immune cells to control two major life-threatening complications, namely graft-vs-host disease (GvHD) and cancer relapse, which typically ...
Sep 27, 2022
0
15
The oncogene EVI1 causes an aggressive type of leukemia, but its exact function has been a mystery. A research team led by scientists from Vienna now showed that EVI1's cancer causing effect relies on activating a single ...
Sep 20, 2022
0
71
"Why did my child get cancer?"
Sep 8, 2022
0
35
Most of the U.S. blood supply comes from about 5 million altruistic volunteers who donate blood regularly. Frequent blood donation is known to result in iron deficiency in donors, which has led to concerns that the practice ...
Sep 7, 2022
0
5
In the condition known as cerebral cavernoma, lesions arise in a cluster of blood vessels in the brain. In a new study from Uppsala University, researchers show that blood coagulation and blood clot formation are very relevant ...
Aug 24, 2022
0
10
A type of blood cell cancer called angioimmunoblastic T-cell lymphoma (AITL) can develop as mutations accumulate with age in the stem cells from which the T cells in the blood develop. However, the underlying mechanism by ...
Aug 12, 2022
0
2
Scientists at St. Jude Children's Research Hospital are improving chimeric antigen receptor (CAR) T-cell therapy. Their new simplified approach selected for an advantageous T-cell type and showed promise in the lab against ...
Aug 5, 2022
0
39
A new insight into RNA regulation has taken researchers a big step forward in understanding how the body creates platelets.
Jul 5, 2022
0
37
A research team led by Prof. Dr. Tamam Bakchoul from the Institute for Clinical and Experimental Transfusion Medicine (IKET) at the University Hospital of Tübingen is investigating the suitability of anticoagulants in patients ...
Jun 23, 2022
0
2
Acute lymphoblastic leukemia (ALL) is the most common cancer affecting children. The T-ALL form of leukemia that emerges from early T lineage cells has a poorer prognosis than B-lineage ALL. The prognosis for relapsed T-ALL ...
Jun 20, 2022
0
14
